|
Sign In to gain access to subscriptions and/or personal tools.
|
Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light
Gautam Ramakrishna
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA
Thom W Rooke
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA
Leslie T Cooper
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA, cooper.leslie{at}mayo.edu
The relationship between iron status and atherosclerosis has long been a topic of debate in the literature. Despite more than 25 years of research, there is no consensus regarding a causal relationship. To date, the vast majority of studies have focused on iron burden with respect to a hypothesized role in the onset and progression of coronary artery disease. However, the effect of iron in the coronary arterial system may differ mechanistically and therefore clinically from its effect in the peripheral arterial system. This review will summarize the biochemical, pathologic, animal, and clinical research data with respect to iron and atherosclerosis. This background will be expanded upon to provide insights into ongoing studies and paths for future investigations into the role of iron and peripheral arterial disease.
Key Words: atherosclerosis • coronary artery disease • iron • oxidative stress • peripheral arterial disease
Vascular Medicine, Vol. 8, No. 3,
203-210 (2003)
DOI: 10.1191/1358863x03vm493ra
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
C. P. Kovesdy, G. H. Lee, and K. Kalantar-Zadeh
Serum Ferritin: Deceptively Simple or Simply Deceptive? Lessons Learned From Iron Therapy in Patients With Chronic Kidney Disease
Journal of Pharmacy Practice,
December 1, 2008;
21(6):
411 - 419.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Y.-H. Chen, L.-Y. Chau, J.-W. Chen, and S.-J. Lin
Serum Bilirubin and Ferritin Levels Link Heme Oxygenase-1 Gene Promoter Polymorphism and Susceptibility to Coronary Artery Disease in Diabetic Patients
Diabetes Care,
August 1, 2008;
31(8):
1615 - 1620.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Li, L.-H. Xu, C. Forssell, J. L. Sullivan, and X.-M. Yuan
Overexpression of Transferrin Receptor and Ferritin Related to Clinical Symptoms and Destabilization of Human Carotid Plaques
Experimental Biology and Medicine,
July 1, 2008;
233(7):
818 - 826.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Merle, E. Fein, S. G. Gehrke, W. Stremmel, and H. Kulaksiz
The Iron Regulatory Peptide Hepcidin Is Expressed in the Heart and Regulated by Hypoxia and Inflammation
Endocrinology,
June 1, 2007;
148(6):
2663 - 2668.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. R. Zacharski, B. K. Chow, P. S. Howes, G. Shamayeva, J. A. Baron, R. L. Dalman, D. J. Malenka, C. K. Ozaki, and P. W. Lavori
Reduction of Iron Stores and Cardiovascular Outcomes in Patients With Peripheral Arterial Disease: A Randomized Controlled Trial
JAMA,
February 14, 2007;
297(6):
603 - 610.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. J. Brewer
Iron and Copper Toxicity in Diseases of Aging, Particularly Atherosclerosis and Alzheimer's Disease
Experimental Biology and Medicine,
February 1, 2007;
232(2):
323 - 335.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Ferrara and W. R. Taylor
Iron Chelation and Vascular Function: In Search of the Mechanisms
Arterioscler Thromb Vasc Biol,
November 1, 2005;
25(11):
2235 - 2237.
[Full Text]
[PDF]
|
|
|
|
|
